Suchergebnisse - "Derosa, Giuseppe"

PubPharm (33)

1

Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies : A Randomized, Controlled, Clinical Trial

enthalten in: Medicine | 2016

von Derosa, G. | Mugellini, A. | Pesce, R. | +2

2

A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus : effects on some new emerging biomarkers of cardiovascular risk

enthalten in: Cardiovascular diabetology | 2015

von Derosa, G. | Mugellini, A. | Pesce, R. | +2

3

A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk

enthalten in: Cardiovascular diabetology | 2015

von Derosa, G. | Mugellini, A. | Pesce, R. | +2

4

A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk

enthalten in: Cardiovascular diabetology | 2015

von Derosa, G. | Mugellini, A. | Pesce, R. | +2

5

Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria

enthalten in: Expert opinion on pharmacotherapy | 2014

von Fogari, R. | Derosa, G. | Zoppi, A. | +3

6

Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients

enthalten in: Inflammation | 2014

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionIn: Derosa G, Cicero AF, Carbone A, Querci F, Fogari E, D'Angelo A, Maffioli P. Inflammation. 2016 Feb;39(1):502. - PMID 26238280

7

Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2014

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionIn: Eur J Pharm Sci. 2018 Oct 15;123:584. - PMID 30190057

8

Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies

enthalten in: Expert opinion on drug safety | 2013

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionIn: Expert Opin Drug Saf. 2015 Oct;14(10):1647. - PMID 26394772

9

Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients

enthalten in: Clinical and experimental hypertension (New York, N.Y. : 1993) | 2013

von Derosa, G. | Cicero, A. | Carbone, A. | +4

10

Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies

enthalten in: Journal of the American Society of Hypertension : JASH | 2013

von Derosa, G. | Cicero, A. | Carbone, A. | +4

RetractionIn: J Am Soc Hypertens. 2015 Oct;9(10):821. - PMID 30153105